Home › Polymyositis › Texas
Polymyositis clinical trials in Texas
3 studies for Polymyositis are looking for participants at sites in Texas.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Allen
- Research Site, Amarillo
- Research Site, Austin
- and 4 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT06455449A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Integrative Rheumatology of South Texas, Edinburg
- Arthritis & Rheumatology Research Institute, PLLC, Frisco
- Integrative Rheumatology of South Texas, Harlingen
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- Arthritis & Rheumatology Research Institute, PLLC, Frisco
- Nerve & Muscle Center of Texas, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06698796From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.